Substance / Medication

Lente human insulin

Overview

Active Ingredient
lente insulin, human
RxNorm CUI
314683

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

948 trials linked to this intervention

948
Total Trials
110
Recruiting
300
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Model-Based Meta-Analysis of the Relationship Between Pioglitazone and Histological Outcomes in Metabolic Dysfunction-Associated Steatohepatitis Patients.
Tran Quyen Thi, Bui Tham Thi, Ngo Lien Thi et al. · CPT Pharmacometrics Syst Pharmacol · 2026
PMID: 40248984Meta-AnalysisFull text (PMC)
Effect of diabetes and hyperglycaemia on the physical and mechanical properties of dentine: a systematic review.
Hwang Kuan-Chieh, Choi Joanne Jung Eun, Hussaini Haizal Mohd et al. · Clin Oral Investig · 2025
PMID: 39792250Meta-AnalysisFull text (PMC)
Unlocking the power of empagliflozin: Rescuing inflammation in hyperglycaemia-exposed human cardiomyocytes through comprehensive multi-level analysis.
Benedetti Rosaria, Chianese Ugo, Papulino Chiara et al. · Eur J Heart Fail · 2025
PMID: 39809551Meta-AnalysisFull text (PMC)
Management of Diabetes and Hyperglycemia in the Hospital: A Systematic Review of Clinical Practice Guidelines.
Wilson Linnea M, Herzig Shoshana J, Marcantonio Edward R et al. · Diabetes Care · 2025
PMID: 40117466Meta-AnalysisFull text (PMC)
The role of the Helianthus genus in Hyperglycemia: A systematic review with meta-analysis.
Barreto Marina Dos Santos, Santos Ronaldy Santana, Souza Jessiane Bispo de et al. · Fitoterapia · 2025
PMID: 40204043Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Lente human insulin (substance)
SNOMED CT
422346007
UMLS CUI
C0982219
RxNorm CUI
314683

Clinical Data

This intervention maps to 13 entities in the Ltrl knowledge graph.

4
Conditions
4
Biomarkers
3
Specialists
0
Symptoms
948
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.